Veracyte Inc (VCYT) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Veracyte Inc   (NASDAQ: VCYT)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Veracyte Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



VCYT Gross Profit Margin (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Revenue Change 23.45 %
Seq. Revenue Change 12.05 %
Revenue In Millions $150.32
Gross Profit Margin 98.18 %
Gross Profit Margin Total Ranking # 821
Gross Profit In Millions $147.58
Y / Y Gross Profit Change 64.4 %
Seq. Gross Profit Change 45.89 %


Commenting Second Quarter 2026 Gross Profit Margin
Veracyte Inc Gross Profit grew by 45.89 % in Q2 sequentially to 148 millions, while Revenue increased by 12.05 %, this led to improvement in the company's Gross Profit Margin to 98.18 % a new company high.


Observing second quarter 2026 results within Medical Laboratories industry 7 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 821, from total ranking in the previous quarter at 878.
Learn about Gross Margin
VCYT's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Medical Laboratories Industry # 8
Healthcare Sector # 146
Overall # 815

Gross Profit Margin Statistics
High Average Low
98.18 % 67.48 % 41.15 %
(Jun 30 2026)   (Dec 31 2020)




Other Gross Profit Margin Profitability Ratios
VCYT's Cumulative Gross Profit Margin
Medical Laboratories Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
VCYT's Gross Profit Margin Profitability versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for VCYT's Competitors
Gross Profit Margin Profit Margin for Veracyte Inc 's Suppliers
Gross Profit Margin Profit Margin for VCYT's Customers

You may also want to know
VCYT's Annual Growth Rates VCYT's Profitability Ratios VCYT's Asset Turnover Ratio VCYT's Dividend Growth
VCYT's Roe VCYT's Valuation Ratios VCYT's Financial Strength Ratios VCYT's Gross Profit Growth
VCYT's Roa VCYT's Inventory Turnover Ratio VCYT's Growth Rates VCYT's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Medical Laboratories Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue
Veracyte Inc   98.18 %$ 147.580  Millions$ 150.321  Millions
Castle Biosciences Inc   77.11 %$ 79.846  Millions$ 103.546  Millions
Maxcyte inc   76.96 %$ 5.596  Millions$ 7.271  Millions
Butterfly Network Inc   71.41 %$ 23.288  Millions$ 32.612  Millions
Billiontoone Inc   70.45 %$ 77.107  Millions$ 109.448  Millions
Nuo Therapeutics, Inc.  66.14 %$ 1.170  Millions$ 1.769  Millions
Guardant Health Inc   65.39 %$ 219.029  Millions$ 334.978  Millions
Nrc Health  61.67 %$ 21.828  Millions$ 35.392  Millions
Exagen Inc   61.27 %$ 12.217  Millions$ 19.941  Millions
Ispecimen inc   45.18 %$ 0.069  Millions$ 0.152  Millions
Quest Diagnostics Inc  33.75 %$ 1,027.000  Millions$ 3,043.000  Millions
Aclarion Inc   32.93 %$ 0.008  Millions$ 0.025  Millions
Fulgent Genetics Inc   30.07 %$ 25.679  Millions$ 85.389  Millions
Labcorp Holdings Inc   29.80 %$ 1,112.000  Millions$ 3,731.100  Millions
Medpace Holdings Inc   28.51 %$ 201.637  Millions$ 707.331  Millions
Personalis Inc   21.21 %$ 4.743  Millions$ 22.357  Millions
Fortrea Holdings Inc   20.52 %$ 139.200  Millions$ 678.200  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.